glycine has been researched along with Kidney Failure, Chronic in 53 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, was evaluated in a phase 1b study in patients with end-stage renal disease with anemia on hemodialysis." | 9.34 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients. ( Chou, J; Hemmerich, S; Neff, TB; Provenzano, R; Tumlin, J; Yu, KP; Zabaneh, R, 2020) |
| " PK and adverse events (AEs) were assessed after a single 3 mg dose of ixazomib." | 6.82 | A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis. ( Badros, A; Berdeja, J; Chari, A; Gupta, N; Hanley, MJ; Harvey, RD; Hui, AM; Kukreti, V; Lipe, B; Qian, M; Venkatakrishnan, K; Yang, H; Zhang, X, 2016) |
| "We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the treatment of chronic kidney disease-related anemia in patients new to dialysis." | 5.41 | Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. ( Besarab, A; Bradley, C; Eremeeva, L; Eyassu, M; Korneyeva, S; Leong, R; Liu, CS; Neff, TB; Poole, L; Provenzano, R; Saha, G; Shutov, E; Szczech, L; Yu, KP, 2021) |
| "Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, was evaluated in a phase 1b study in patients with end-stage renal disease with anemia on hemodialysis." | 5.34 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients. ( Chou, J; Hemmerich, S; Neff, TB; Provenzano, R; Tumlin, J; Yu, KP; Zabaneh, R, 2020) |
| " PK and adverse events (AEs) were assessed after a single 3 mg dose of ixazomib." | 2.82 | A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis. ( Badros, A; Berdeja, J; Chari, A; Gupta, N; Hanley, MJ; Harvey, RD; Hui, AM; Kukreti, V; Lipe, B; Qian, M; Venkatakrishnan, K; Yang, H; Zhang, X, 2016) |
| "Ximelagatran is an oral direct thrombin inhibitor currently in clinical development as an anticoagulant for the prevention and treatment of thromboembolic disease." | 2.71 | Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran. ( Attman, PO; Eriksson, UG; Fager, G; Frison, L; Johansson, S; Mulec, H; Samuelsson, O, 2003) |
| "Type 1 primary hyperoxaluria is a genetic disorder caused by deficiency of the liver-specific peroxisomal enzyme alanine-glyoxylate aminotransferase." | 2.49 | Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria. ( Fillaus, JA; Plumb, TJ; Swee, ML, 2013) |
| " The fact that the concentrations of neither GAA nor Arg changed significantly after the injection of 14C-Arg in either group suggested that the dosage of injected Arg is not sufficient to affect the transformation of Arg to GAA." | 1.29 | Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid. ( Kuroda, M, 1993) |
| "Five patients with chronic renal failure taking a diet containing approximately 5 g N throughout were studied during two periods of 1 month each." | 1.26 | Metabolic studies with keto acid diets. ( Ell, S; Fynn, M; Halliday, D; Richards, P, 1978) |
| "3 ml/min/kg), terminal half-life (148 min), and total volume of distribution (1." | 1.25 | Pharmacokinetics and metabolism of lidocaine in patients with renal failure. ( Atkinson, AJ; Collinsworth, KA; Harrison, DC; Perlroth, F; Strong, JM; Winkle, RA, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (50.94) | 18.7374 |
| 1990's | 11 (20.75) | 18.2507 |
| 2000's | 6 (11.32) | 29.6817 |
| 2010's | 5 (9.43) | 24.3611 |
| 2020's | 4 (7.55) | 2.80 |
| Authors | Studies |
|---|---|
| Csiky, B | 1 |
| Schömig, M | 1 |
| Esposito, C | 1 |
| Barratt, J | 1 |
| Reusch, M | 1 |
| Valluri, U | 1 |
| Sulowicz, W | 1 |
| Provenzano, R | 3 |
| Tumlin, J | 1 |
| Zabaneh, R | 1 |
| Chou, J | 1 |
| Hemmerich, S | 2 |
| Neff, TB | 3 |
| Yu, KP | 2 |
| Shutov, E | 1 |
| Eremeeva, L | 1 |
| Korneyeva, S | 1 |
| Poole, L | 2 |
| Saha, G | 2 |
| Bradley, C | 1 |
| Eyassu, M | 1 |
| Besarab, A | 2 |
| Leong, R | 1 |
| Liu, CS | 1 |
| Szczech, L | 2 |
| Wu, R | 1 |
| Peng, Y | 1 |
| Wish, JB | 1 |
| Plumb, TJ | 1 |
| Swee, ML | 1 |
| Fillaus, JA | 1 |
| Wright, S | 1 |
| Dua, S | 1 |
| Zeig, S | 1 |
| Nguyen, P | 1 |
| Saikali, KG | 1 |
| Yu, KH | 1 |
| Gupta, N | 1 |
| Hanley, MJ | 1 |
| Harvey, RD | 1 |
| Badros, A | 1 |
| Lipe, B | 1 |
| Kukreti, V | 1 |
| Berdeja, J | 1 |
| Yang, H | 1 |
| Hui, AM | 1 |
| Qian, M | 1 |
| Zhang, X | 1 |
| Venkatakrishnan, K | 1 |
| Chari, A | 1 |
| Locatelli, F | 1 |
| Fishbane, S | 1 |
| Block, GA | 1 |
| Macdougall, IC | 1 |
| Hyndman, ME | 1 |
| Manns, BJ | 1 |
| Snyder, FF | 1 |
| Bridge, PJ | 1 |
| Scott-Douglas, NW | 1 |
| Fung, E | 1 |
| Parsons, HG | 1 |
| Eriksson, UG | 2 |
| Johansson, S | 1 |
| Attman, PO | 2 |
| Mulec, H | 1 |
| Frison, L | 1 |
| Fager, G | 2 |
| Samuelsson, O | 2 |
| Rothe, HM | 1 |
| Shapiro, WB | 1 |
| Sun, WY | 1 |
| Chou, SY | 1 |
| Ottosson, P | 1 |
| Eriksson-Lepkowska, M | 1 |
| Chu, Y | 1 |
| Alwahdani, A | 1 |
| Iida, S | 1 |
| Lund, DD | 1 |
| Faraci, FM | 1 |
| Heistad, DD | 1 |
| Robertz, GM | 1 |
| Dengler, HJ | 1 |
| Sterner, G | 2 |
| Asp, NG | 1 |
| Dahlqvist, A | 1 |
| Denneberg, T | 2 |
| Lindberg, T | 2 |
| Mitch, WE | 1 |
| Brusilow, S | 1 |
| Gold, CH | 1 |
| Viljoen, M | 1 |
| Mzamane, DV | 1 |
| Mikami, H | 1 |
| Orita, Y | 1 |
| Ando, A | 1 |
| Fujii, M | 1 |
| Kikuchi, T | 1 |
| Yoshihara, K | 1 |
| Okada, A | 1 |
| Abe, H | 1 |
| Ochiai, Y | 1 |
| Abe, S | 1 |
| Yamada, T | 1 |
| Tada, K | 1 |
| Kosaka, F | 1 |
| Levillain, O | 2 |
| Marescau, B | 2 |
| de Deyn, PP | 2 |
| Garibotto, G | 1 |
| Deferrari, G | 1 |
| Robaudo, C | 1 |
| Saffioti, S | 1 |
| Sofia, A | 1 |
| Russo, R | 1 |
| Tizianello, A | 1 |
| Lever, M | 1 |
| Sizeland, PC | 1 |
| Bason, LM | 1 |
| Hayman, CM | 1 |
| Robson, RA | 1 |
| Chambers, ST | 1 |
| Geissler, A | 1 |
| Fründ, R | 1 |
| Kohler, S | 1 |
| Eichhorn, HM | 1 |
| Krämer, BK | 1 |
| Feuerbach, S | 1 |
| Kuroda, M | 1 |
| Renieri, A | 1 |
| Bruttini, M | 1 |
| Galli, L | 1 |
| Zanelli, P | 1 |
| Neri, T | 1 |
| Rossetti, S | 1 |
| Turco, A | 1 |
| Heiskari, N | 1 |
| Zhou, J | 1 |
| Gusmano, R | 1 |
| Massella, L | 1 |
| Banfi, G | 1 |
| Scolari, F | 1 |
| Sessa, A | 1 |
| Rizzoni, G | 1 |
| Tryggvason, K | 1 |
| Pignatti, PF | 1 |
| Savi, M | 1 |
| Ballabio, A | 1 |
| De Marchi, M | 1 |
| Guth, HJ | 1 |
| Wiersbitzky, M | 1 |
| Ziesche, M | 1 |
| Rose, HJ | 1 |
| Kraatz, G | 1 |
| Ishihara, T | 1 |
| Yokota, N | 1 |
| Hisanaga, S | 1 |
| Fujimoto, S | 1 |
| Hirayama, N | 1 |
| Kato, J | 1 |
| Kitamura, K | 1 |
| Eto, T | 1 |
| Possemiers, I | 1 |
| Al Banchaabouchi, M | 1 |
| Ell, S | 1 |
| Fynn, M | 1 |
| Richards, P | 2 |
| Halliday, D | 1 |
| Bosseckert, H | 1 |
| Collinsworth, KA | 1 |
| Strong, JM | 1 |
| Atkinson, AJ | 1 |
| Winkle, RA | 1 |
| Perlroth, F | 1 |
| Harrison, DC | 1 |
| Yokozawa, T | 1 |
| Fujitsuka, N | 1 |
| Oura, H | 1 |
| Macpherson, NA | 1 |
| Moscarello, MA | 1 |
| Goldberg, DM | 1 |
| Ish-Shalom, N | 1 |
| Arbus, GS | 1 |
| Druml, W | 1 |
| Lochs, H | 1 |
| Roth, E | 1 |
| Hübl, W | 1 |
| Balcke, P | 1 |
| Lenz, K | 1 |
| Jiang, J | 1 |
| Wigger, M | 1 |
| Stolpe, HJ | 1 |
| Heine, W | 1 |
| Wutzke, K | 1 |
| Töwe, J | 1 |
| Lumlertgul, D | 1 |
| Burke, TJ | 1 |
| Gillum, DM | 1 |
| Alfrey, AC | 1 |
| Harris, DC | 1 |
| Hammond, WS | 1 |
| Schrier, RW | 1 |
| Houghton, BJ | 1 |
| Brown, CL | 1 |
| Thompson, E | 1 |
| Dotchev, D | 1 |
| Hungerland, H | 1 |
| Liappis, N | 1 |
| Oyanagi, K | 1 |
| Krempien, B | 1 |
| Ritz, E | 1 |
| Schmidt, G | 1 |
| Aleutskiĭ, NN | 1 |
| Nifontova, VV | 1 |
| Sul'din, AIa | 1 |
| Gardner, B | 1 |
| Gray, H | 1 |
| Hedayati, H | 1 |
| Pütter, J | 1 |
| Daneels, R | 1 |
| Chang, GN | 1 |
| Fam, A | 1 |
| Little, AH | 1 |
| Malkin, A | 1 |
| Walls, WD | 1 |
| Losowsky, MS | 1 |
| Simon, NM | 1 |
| Bell, NH | 1 |
| Del Greco, F | 1 |
| Czerniak, Z | 2 |
| Burzyński, S | 1 |
| Young, GA | 1 |
| Parsons, FM | 1 |
| Minder, FC | 1 |
| Dubach, UC | 1 |
| Antener, I | 1 |
2 reviews available for glycine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
Topics: Adult; Amino Acid Substitution; Arginine; Circadian Rhythm; Combined Modality Therapy; DNA Mutationa | 2013 |
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
Topics: Anemia; Animals; Barbiturates; Blood Pressure; Disease Models, Animal; Drug Design; Drug Interaction | 2017 |
9 trials available for glycine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
Topics: Anemia; Glycine; Hematinics; Hemoglobins; Humans; Isoquinolines; Kidney Failure, Chronic; Renal Dial | 2021 |
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients.
Topics: Administration, Oral; Adult; Aged; Anemia; Area Under Curve; Dose-Response Relationship, Drug; Doubl | 2020 |
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Topics: Anemia; Epoetin Alfa; Erythropoietin; Glycine; Hematinics; Hemoglobins; Humans; Isoquinolines; Kidne | 2021 |
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Epoetin Alfa; Female; Glycine; Hematinics; Humans; Isoquinol | 2016 |
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Blood Proteins; Boron Compounds; Drug | 2016 |
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Topics: Cysteine; Genotype; Glycine; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Me | 2003 |
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Azetidines; Benzylamines; Cross | 2003 |
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Azetidines; Benzylamines; Chronic Disease; Dalteparin; G | 2005 |
Abnormal glycine betaine content of the blood and urine of diabetic and renal patients.
Topics: Adult; Albuminuria; Betaine; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus; Fe | 1994 |
42 other studies available for glycine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Roxadustat on anti-erythropoietin antibody-related pure red cell aplasia in the patient with end-stage renal disease.
Topics: Adult; Erythropoietin; Female; Glycine; Humans; Isoquinolines; Kidney Failure, Chronic; Recombinant | 2021 |
Emerging treatments for anemia in patients with CKD and ESRD.
Topics: Anemia, Iron-Deficiency; Drugs, Investigational; Glycine; Humans; Hypoxia-Inducible Factor-Proline D | 2017 |
Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl.
Topics: Adult; Aged; Alleles; Arginine; Base Sequence; Calcium; Cinacalcet; Clinical Trials as Topic; DNA; E | 2005 |
Vascular effects of the human extracellular superoxide dismutase R213G variant.
Topics: Amino Acid Substitution; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Gene Tra | 2005 |
Endogenous ligand(s) decrease drug--protein binding in uremic sera: a fluorescence probe study.
Topics: Adult; Clofibrate; Clofibric Acid; Dansyl Compounds; Female; Fluorescent Dyes; Glycine; Humans; Kidn | 1983 |
Small intestinal dipeptidases and disaccharidases in experimental uremia in rats.
Topics: alpha-Glucosidases; Animals; beta-Galactosidase; Dipeptidases; Disaccharidases; Glycine; Intestinal | 1980 |
Small intestinal absorption of glycine and glycyl-glycine in patients with chronic renal failure.
Topics: Adult; Aged; Amines; Amino Acids; Dipeptides; Female; Glycine; Glycylglycine; Humans; Intestinal Abs | 1983 |
Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.
Topics: Benzoates; Benzoic Acid; Female; Glomerular Filtration Rate; Glycine; Hippurates; Humans; Kidney Fai | 1982 |
The lack of effect of guanidinoacetic acid on in vitro osmotic fragility of erythrocytes.
Topics: Glycine; Humans; Kidney Failure, Chronic; Osmotic Fragility; Renal Dialysis | 1982 |
Metabolic pathway of guanidino compounds in chronic renal failure.
Topics: Animals; Arginine; Blood Urea Nitrogen; Creatinine; Glycine; Guanidines; Kidney Failure, Chronic; Ma | 1982 |
Guanidino compounds and hemodialysis.
Topics: Acute Kidney Injury; Blood Urea Nitrogen; Creatinine; Glycine; Guanidines; Hepatic Encephalopathy; H | 1982 |
Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Topics: Animals; Arginine; Creatine; Glycine; Guanidines; Homoarginine; Kidney; Kidney Failure, Chronic; Mal | 1995 |
Disposal of exogenous amino acids by muscle in patients with chronic renal failure.
Topics: Adult; Amino Acids; Analysis of Variance; Female; Glycine; Histidine; Humans; Insulin; Kidney Failur | 1995 |
Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glycine; Humans; Inositol; Kidney Failure, C | 1995 |
Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid.
Topics: Animals; Arginine; Blood Urea Nitrogen; Carbon Radioisotopes; Glycine; Kidney Failure, Chronic; Rabb | 1993 |
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.
Topics: Adult; Age of Onset; Amino Acid Sequence; Base Sequence; Codon; Collagen; DNA Primers; DNA Transposa | 1996 |
Which amino-acids do serum and hemofiltrate of critically ill patients with acute renal failure contain?
Topics: Alanine; Amino Acids; Asparagine; Citrulline; Cystathionine; Ethanolamines; Extracorporeal Circulati | 1997 |
Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
Topics: Adrenomedullin; Adult; Aged; Atrial Natriuretic Factor; Calcitonin Gene-Related Peptide; Creatinine; | 1999 |
Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Topics: Acute Kidney Injury; Animals; Arginine; Creatine; Creatinine; Glycine; Guanidines; Homoarginine; Kid | 2001 |
Metabolic studies with keto acid diets.
Topics: Aged; Female; Glycine; Humans; Keto Acids; Kidney Failure, Chronic; Male; Middle Aged; Nitrogen; Ure | 1978 |
[Gastroenterologic diseases and their relationship to the urogenital system].
Topics: Amyloidosis; Bile Acids and Salts; Celiac Disease; Cholelithiasis; Cholestyramine Resin; Colitis, Ul | 1978 |
Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
Topics: Computers; Ethylamines; Glycine; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Lidocaine; Xy | 1975 |
Studies on the precursor of methylguanidine in rats with renal failure.
Topics: Animals; Arginine; Creatinine; Glycine; Kidney; Kidney Failure, Chronic; Liver; Male; Methylguanidin | 1991 |
Aminoaciduria as a marker of acute renal transplant rejection--a patient study.
Topics: Adolescent; Alanine; Amino Acids; Child; Child, Preschool; Creatinine; Female; Glycine; Graft Reject | 1991 |
Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans.
Topics: Adult; Creatinine; Dipeptides; Female; Glycine; Half-Life; Humans; Kidney Failure, Chronic; Male; Me | 1991 |
[Whole-body protein turnover and plasma glycine kinetics in chronic renal failure before and after treatment with essential amino acids].
Topics: Adult; Amino Acids, Essential; Female; Glycine; Humans; Kidney Failure, Chronic; Kinetics; Male; Mid | 1987 |
15N tracer kinetic investigations on the protein metabolism in a child with chronic renal failure fed a protein-restricted diet.
Topics: Adolescent; Amino Acids, Essential; Dietary Proteins; Female; Glycine; Humans; Kidney Failure, Chron | 1988 |
Phosphate depletion arrests progression of chronic renal failure independent of protein intake.
Topics: Aluminum Hydroxide; Animals; Blood Pressure; Blood Urea Nitrogen; Calcium; Cholesterol; Creatinine; | 1986 |
Synthesis of phenylalanine and valine by healthy and uraemic men.
Topics: Adult; Amino Acids; Ammonium Chloride; Carbon; Diet; Female; Glycine; Humans; Keto Acids; Kidney; Ki | 1971 |
[Hyperiminoaciduria and disaminoaciduria in endemic (Balkan-)nephropathy (author's transl)].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Thin Layer; Chronic Disease; Creatinine; Female; | 1974 |
[Experimental autoradiographic investigations of the collagen metabolism of bone in uremia].
Topics: Acute Kidney Injury; Animals; Autoradiography; Bone and Bones; Collagen; Glycine; Kidney Failure, Ch | 1972 |
[The therapeutic effect of morphocycline, glycocycline and reverin in experimental nephritis both complicated and not complicated by infection].
Topics: Animals; Basement Membrane; Female; Glycine; Immune Sera; Kidney Failure, Chronic; Kidney Glomerulus | 1974 |
Bone collagenase in osteolytic stress of rats and humans.
Topics: Animals; Biological Assay; Bone Resorption; Breast Neoplasms; Carbon Isotopes; Glycine; Humans; Hype | 1970 |
[Qualitative chromatographic determination of the conjugates of salicylic and salicyluric acids in blood plasma and urine].
Topics: Aspirin; Chromatography, Thin Layer; Glucuronates; Glycine; Humans; Hydrolysis; Kidney Failure, Chro | 1974 |
The uptake of glycine-14C into the adenine and guanine of DNA and insoluble RNA of human leucocytes.
Topics: Adenine; Autoanalysis; Carbon Radioisotopes; Chromatography, Paper; DNA; Female; Glycine; Gout; Guan | 1974 |
Abnormalities of fibrin stabilization in liver and kidney disease: a comparison of two different methods.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Chronic Disease; Factor XIII; Female; Glycine; Hemorrh | 1969 |
Iminoacidopathy in renal failure.
Topics: Calcium; Glycine; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Fa | 1970 |
N-substituted amino acids in serum of patients with chronic renal insufficiency.
Topics: Alanine; Amino Acids; Aspartic Acid; Cystine; Glutamates; Glycine; Humans; Kidney Failure, Chronic; | 1970 |
[Free, N-substituted and peptide amino acids in urine of patients with chronic renal insufficiency].
Topics: Adult; Aged; Amino Acid Metabolism, Inborn Errors; Amino Acids; Aspartic Acid; Female; Glycine; Huma | 1970 |
Bound amino acids in serum of patients with chronic renal insufficiency.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Aspartic Acid; Chromatography, Paper; Female; Glomer | 1969 |
The effect of peritoneal dialysis upon the amino acids and other nitrogenous compounds in the blood and dialysates from patients with renal failure.
Topics: Adult; Amino Acids; Aspartic Acid; Butyrates; Creatinine; Diet Therapy; Female; Glutamates; Glycine; | 1969 |
[Hereditary nephropathy and hardness of hearing (with metabolic disorders of amino acids and fats in a family from Switzerland)].
Topics: Adolescent; Adult; Aged; Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Deafness; Dw | 1965 |